MOF, MOH Form Joint Committee To Tackle Rising Private Healthcare Costs
The committee, which convened its first meeting today, will coordinate a whole-of-nation approach to collaboratively develop and implement measures aligned with value-based healthcare.
The JMCPHC is co-chaired by Finance Minister II Datuk Seri Amir Hamzah Azizan and Health Minister Datuk Seri Dr Dzulkefly Ahmad, with committee members consisting of representatives from MOF, MOH, and Bank Negara Malaysia (BNM).
The committee will be supported with inputs and technical advice by a Consultative Council, comprising representatives from key stakeholders across the private healthcare ecosystem, including private hospitals, insurance providers and Takaful operators (ITOs).
'Rising healthcare costs are a major concern for Malaysians, and the MADANI Government is taking the lead to address it. This joint committee reflects our commitment to work with all stakeholders to shape a private healthcare system that is sustainable, transparent, and delivers real value.
'At its core, this is about protecting the wellbeing of Malaysians and strengthening the resilience of our nation,' Amir Hamzah said in a joint statement by the two ministries today.
He said the JMCPHC builds upon previous groundwork, including BNM's implementation of co-pay requirements, interim measures to cushion the impact of medical premium adjustments for policyholders affected in 2024–2026, and the RESET framework.
It covers five strategic thrusts to address medical inflation, namely: Revamp Medical and Health Insurance/Takaful (MHIT); Enhance price transparency; Strengthen the Digital Health ecosystem; Expand cost-effective options; and Transform provider payments.
RESET is broadly endorsed and supported by MOF, MOH, BNM, and key industry stakeholders as the strategic framework to address rising private healthcare and insurance costs.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
3 hours ago
- The Star
When you have to juggle multiple medications
The Malaysian population is rapidly ageing, with over 11% currently aged 60 and above. This figure is projected to rise to 17.3% by 2040. The demographic shift has led to increasing healthcare demands, particularly in managing chronic diseases such as diabetes, hypertension (high blood pressure) and heart disease. These conditions require long-term medicine use. Alarmingly, studies indicate that nearly half of older Malaysians experience polypharmacy. Many are also prescribed potentially inappropriate medications or fail to adhere to their treatment regimens. This issue calls for coordinated care, increased awareness and targeted interventions. Understanding polypharmacy Polypharmacy is generally defined as the use of five or more medicines at the same time. However, the number of medicines alone does not determine the impact. The necessity and appropriateness of these medicines are equally important. Polypharmacy can be both beneficial and harmful. Appropriate polypharmacy occurs when multiple medicines are clinically necessary, carefully monitored and effectively managed. For example, a person with high blood pressure, diabetes and heart disease may require several medicines to maintain stable health. Problematic polypharmacy occurs when medicines are prescribed to treat the side effects of other medicines (a situation known as a prescribing cascade), or when the medicines themselves are potentially harmful. Polypharmacy is common among older adults for several reasons. Understanding these contributing factors is essential in order to design effective strategies to minimise medicines-related harm and improve overall patient care. Some of the factors that can be attributed to the high frequency of polypharmacy among older adults are: The presence of multiple chronic medical conditions, for which the long-term use of medicines is necessary, Prescription of medicines on multiple different occasions by different healthcare practitioners, which increases the risk of duplication or drug interaction. Prescribing cascades, where medicines are prescribed to treat the side effects caused by other medicines. The absence of regular medicine reviews, which may allow unnecessary or outdated prescriptions to continue without reassessment. Poor communication between patients and healthcare providers, which can result in confusion or misuse of medicines. Widespread and accessible pharmaceutical promotions, which encourage patients to use traditional or over-the-counter medicines alongside prescribed medicines without medical advice. Potential dangers Polypharmacy carries genuine and significant risks, especially for older adults. Community pharmacists are one resource patients can easily access to ensure that their medicine regime is up-to-date and not causing any unnecessary side effects. — Filepic Due to slower metabolisms and potentially impaired kidney function, the elderly are more vulnerable to the negative effects of multiple medicines. Some of the most concerning consequences include emergency hospitalisations due to medicine-related complications, drug interactions that lead to undesirable side effects or reduced effectiveness, and adverse side effects such as dizziness, confusion or gastrointestinal issues. In addition, when medicines impair alertness or physical coordination, they may contribute to falls, fractures and cognitive decline. Several studies conducted in Malaysia also show that the majority of older adults do not take their medicines as prescribed. Polypharmacy has a direct impact on medication adherence, which refers to how well patients follow their prescribed treatment plans. As the number of prescribed medicines increases, the elderly often struggle with complex dosing schedules, leading to missed or incorrect doses. This not only compromises treatment outcomes, but also increases the risk of hospitalisations and complications. To address these, it is essential to provide patient education, simplify medicine regimens, and offer support through technology and caregiver involvement. Reducing the risks Healthcare systems around the world are adopting more proactive strategies to ensure the safe and effective use of medicines, especially in light of growing concerns about polypharmacy. One important strategy is regular medicine reviews. Patients are encouraged to inform their doctors and pharmacists about all the medicines they are taking, including prescriptions, over-the-counter products and supplements. This open communication allows more regular medicine reviews, which helps healthcare providers identify medicines that may no longer be necessary or could be potentially harmful. Another key practice is deprescribing, which involves gradually reducing or stopping medicines that are no longer beneficial. Medicine reconciliation is also essential. This process ensures that any changes to a patient's medicine list, such as during hospital admission, discharge or transfer to a nursing home, are accurate and appropriate. Technology also plays a helpful role. Electronic health records can alert healthcare providers to potential interactions or duplicate medicines. Most importantly, a patient-centred approach is needed. When patients are involved in decisions about their treatment, it builds trust, improves adherence to medicines and leads to better health outcomes. The most effective strategies to manage polypharmacy involve active participation from both patients and their caregivers. Several steps are encouraged to support safe medication use: Maintain an updated medicines list, including over-the-counter products, supplements and herbal remedies. Bring this list to every medical appointment. Ask your doctor or pharmacist about the purpose, benefits and possible side effects of each medicine. Inform your doctor or pharmacist when you experience side effects, especially if they are suspected to be caused by a medicine. Get help from pharmacists for medicine reviews, especially after hospital stays or when there is a change in the medicine regimen. Use adherence devices or tools to help take medicines correctly, such as pill boxes, mobile apps or mobile alarms. The role of pharmacists As the number of elderly individuals taking multiple medications daily continues to rise, the role of pharmacists has become increasingly vital. While doctors are responsible for diagnosing conditions and prescribing treatments, pharmacists ensure that medications are used safely, correctly and effectively. With specialised knowledge in pharmacology and drug interactions, pharmacists are often able to detect issues that may be overlooked by others. These include overlapping therapies, potentially harmful drug combinations, and unnecessary or duplicate prescriptions. Community pharmacists, in particular, are in a unique position to support patients directly. As the most accessible healthcare professionals, they can offer personalised counselling, conduct routine medication reviews and help patients understand the purpose and proper use of each medicine. They can also identify early signs of adverse effects or non-adherence, and refer patients for further medical attention when necessary. Addressing polypharmacy requires a coordinated approach that centres on the patient. As the population grows older, providing safe, effective and individualised treatment is crucial. Balancing illness management with quality of life is key to delivering better and safer care to older adults. For any inquiries regarding medicines, please call the National Pharmacy Call Centre (NPCC) at the toll-free number 1-800-88-6722 during weekdays from 8am to 5pm, except on public holidays. Payal Choudhury is a pharmacist at Hospital Tengku Ampuan Najihah in Kuala Pilah, Negri Sembilan. This article is courtesy of the Health Ministry's Pharmacy Practice and Development Division. For more information, email starhealth@ The information provided is for educational and communication purposes only, and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this article. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.


The Star
4 hours ago
- The Star
MCEF celebrates 50 years of empowering lives through education
KUALA LUMPUR:The Malaysian Community and Education Foundation (MCEF) will mark a significant milestone this year as it celebrates its 50th anniversary on Sept 17. In conjunction with this golden jubilee and to reflect MCEF's commitment to supporting academically excellent students, MCEF is launching the Mendaki Scholarship — a new flagship initiative designed to provide financial support for academically outstanding and well-rounded young Malaysians who aspire to pursue or are pursuing science, technology, engineering and mathematics (STEM) courses, covering computer science, medicine and health sciences, Artificial IntelligenceI/Machine Learning/Robotics at universities in Malaysia commencing with the 2025 academic year. The Mendaki Scholarship, valued at up to RM500,000 per student, will cover the full course fees, accommodation and living expenses for the duration of their undergraduate studies at leading Malaysian public or private universities. 'We are proud of our 50-year journey of service to the community,' said MCEF chairman Ken Pushpanathan. 'To mark 50 years of giving, we are launching the Mendaki Scholarship as a natural progression of our mission — a long-term investment in Malaysia's brightest talents and contributing towards a more equitable future growth of the nation. 'We've named this initiative the Mendaki Scholarship, from the Malay word 'mendaki', which means 'to rise' or 'to ascend.' This name reflects the spirit of the students we aim to support – those who rise against the odds, with ambition and resilience to succeed.' Since its incorporation in 1975, MCEF has been steadfast in its mission to uplift Malaysia's underserved communities by championing education as a key pillar of social progress. Over the past five decades, MCEF has disbursed more than RM152mil towards education, community development, social welfare and the arts. MCEF's key initiatives include support for: > 2,080 Malaysian undergraduates at overseas and local universities who have benefitted from interest-free study loans under MCEF's flagship Student Loan Scheme (SLS) since 1975; > 60,678 young children between the ages of five to six years who were provided early access to education under MCEF's Harapan Preschool Programme (2006 to 2019) which also provided teachers training to 3,586 teachers and teachers' aides including sponsoring some teachers to pursue tertiary education in early child development, before the programme was handed over to the government; > 2,581 secondary school students from underprivileged backgrounds who scored straight 7As in their UPSR examination were awarded annual scholarships up to SPM level under MCEF's Project Ilham (2008 to 2018) aimed at encouraging, guiding and inspiring these students. Annual camps were also held to foster personal growth, leadership and academic motivation; > Various indigenous groups, hard-core poor youths including the academically disadvantaged, marginalised communities, visually impaired individuals and women who have received financial assistance from MCEF's Community and Welfare grants to help them pursue vocational and life skills training; > Students and institutions in the field of creative arts — including dance, music, theatre and film. In line with MCEF's unwavering commitment to academic excellence, it continues to acknowledge and reward outstanding academic performance by converting SLS loans into full scholarships for graduates achieving first-class honours. Applications for the Mendaki Scholarship are now open to eligible Malaysians who have secured full-time undergraduate admissions or are currently pursuing their undergraduate courses at top Malaysian universities until Sept 15. For details on eligibility and how to apply, visit


New Straits Times
4 hours ago
- New Straits Times
How Toyota's 'kaizen' innovation has driven generations
TOYOTA'S presence in Malaysia spans decades, shaped by a steadfast commitment to innovation, quality and customer trust. At the core of the company's success is the Japanese philosophy of 'kaizen', which emphasises continuous improvement — a value that has quietly but powerfully influenced the way Malaysians drive. From its earliest models to today's advanced hybrid systems, Toyota's development process has consistently embraced change. However, rather than change for the sake of novelty, Toyota focuses on enhancing every detail, whether it be performance, safety or user experience. This mindset has been central to its growth, enabling the brand to stay relevant across generations while building vehicles that suit the shifting needs of its customers. A GLOBAL INFLUENCE ON KAIZEN While 'kaizen' is now deeply associated with Toyota, the roots of this approach trace back to early industrial breakthroughs. Inspired by Henry Ford's pioneering assembly line for the Model T, Toyota refined the method with its system of continuous, small improvements. This philosophy came full circle in the 1980s when Toyota helped General Motors revive its underperforming NUMMI plant in Fremont, California. Applying ' kaizen ', Toyota significantly improved quality and productivity, using mostly the same workforce. CARS THAT BECAME MILESTONES Fast forward to today, Toyota's story in Malaysia is reflected in the enduring appeal of some of its most iconic models. In 1968, Malaysians were introduced to the Toyota Corolla, which became one of the best-selling nameplates globally and locally. Its success stemmed from a focus on fuel efficiency, ease of maintenance and affordability. The Hilux, first launched in Malaysia in the 1990s, quickly earned a reputation for toughness. Initially designed for industrial and agricultural use, it has evolved to meet modern lifestyle demands while retaining the rugged reliability that defines the nameplate. Today, it remains one of Toyota's top-selling models, especially in rural and commercial sectors. In the 2000s, Vios entered the market as a compact sedan tailored to younger drivers and small families. Designed with urban mobility in mind, it offered a balance of efficiency, reliability and affordability. Over time, enhancements in safety features, design and drivability have made Vios a staple in many Malaysian households. The Camry, which gained prominence throughout the 2000s and 2010s, has long represented a step up in refinement. Aimed at professionals and executives, its evolution reflects Toyota's attention to comfort, safety and quiet engineering. These models — the Corolla, Hilux, Vios and Camry — differ in form and function, but share a common lineage rooted in practical innovation. Each iteration reflects Toyota's commitment to listening, improving and building vehicles that solve real-world problems for Malaysian drivers. According to a recent report, the Hilux, Vios and Corolla Altis consistently rank among Toyota's best-selling models in Malaysia, a testament to the brand's enduring trust and relevance in the market. ITERATION OVER INVENTION Rather than chasing fleeting trends, Toyota has continuously refined its vehicles through purposeful iteration, a core element of its ' kaizen' philosophy. Feedback from customers, engineers and on-the-ground usage has informed each enhancement, ensuring that updates are grounded in real-world needs. This approach is reflected in Toyota's multi-pathway strategy, which recognises that no single solution fits all markets. Instead of focusing on one powertrain type, Toyota offers a diverse range, from internal combustion to hybrid electric, plug-in hybrid, battery electric and even hydrogen fuel cell technologies. Safety, too, has advanced meaningfully. Through Toyota Safety Sense (TSS) — the company's suite of active safety systems — features like Pre-Collision System, Lane Departure Alert and Dynamic Radar Cruise Control are now offered across a wider range of models. These innovations reflect Toyota's belief that safety should be accessible, not a luxury. ADAPTING TO A NEW ERA Looking ahead, Toyota is once again evolving, this time in step with Malaysia's broader push towards environmental sustainability and carbon neutrality. In support of the National Energy Transition Roadmap (NETR) and Low Carbon Mobility Blueprint, Toyota Malaysia has introduced a growing range of hybrid electric vehicles (HEVs) to offer practical, lower-emission alternatives for local drivers. Models such as the Corolla Cross Hybrid Electric, Camry Hybrid and the recently launched Corolla Cross GR Sport Hybrid reflect this direction, combining fuel efficiency with refined performance. These vehicles are engineered to suit Malaysian roads and driving habits, making sustainable mobility more accessible without compromising reliability. Guided by Toyota's global vision of 'Mobility for All' and the commitment to 'Move Your World', each new model delivers purposeful innovation grounded in long-term value, trust and real-world relevance for Malaysians.